ArticleBMC endocrine disorders2025
Comparison of triglyceride-glucose index and atherogenic index of plasma in euthyroid Hashimoto's thyroiditis patients and healthy controls.
Article in BMC endocrine disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThe relationship between insulin resistance and atherosclerosis in euthyroid Hashimoto’s thyroiditis (HT) remains unclear. This study aimed to compare the atherogenic index of plasma (AIP) and triglyceride–glucose (TyG) index between patients with euthyroid HT and healthy controls. MATERIALS AND
methodsThis retrospective cross-sectional study examined 1,000 patients aged 18–50 who visited the internal medicine outpatient clinic at Mersin City Training and Research Hospital between January 1, 2020, and June 1, 2022. The study population was separated into two groups: 495 adult patients diagnosed with eutyroid HT and a control group of 505 individuals who visited the internal medicine outpatient clinic of our hospital. The two groups were compared with respect to the following parameters: T3, T4, and TSH levels; thyroglobulin antibody (TgAb) and thyroid peroxidase antibody (TPOAb) levels; high-density lipoprotein cholesterol, fasting blood glucose, low-density lipoprotein cholesterol, and triglyceride levels; TyG index; AIP; and body mass index.
resultsPatients with euthyroid HT had higher blood triglyceride, low-density lipoprotein, TgAb, TPOAb levels, AIP, and TyG index than those in the control group (p < 0.001). Correlation analysis showed a moderate significant correlation between AIP and TyG index, TPOAb, and TgAb levels (p < 0.05).
conclusionThe euthyroid HT group exhibited higher AIP and TyG index values than the control group. These findings suggest the presence of insulin resistance and atherosclerosis in patients with HT, independent of thyroid function, and suggest that euthyroid patients with HT should be closely monitored for the development of these conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.